Best Recurrent Miscarriage Treatment Doctors in India

What Women with Recurrent Miscarriage Worry About Most

Three or more pregnancy losses bring grief layered on grief, plus the haunting question of whether the body can ever carry a baby to term. Couples ask whether tests can find a cause, whether thin uterine lining, antiphospholipid syndrome, or chromosomal issues are responsible, whether in vitro fertilisation with preimplantation genetic testing will help, and whether the next pregnancy will succeed. Many recurrent miscarriages have a treatable cause once a structured workup is done, and over sixty percent of couples conceive successfully after investigation and targeted treatment.

How Recurrent Miscarriage Is Investigated

Evaluation after two or three miscarriages includes parental karyotype to look for balanced translocations, antiphospholipid antibody testing (lupus anticoagulant, anticardiolipin, anti-beta-2 glycoprotein), thyroid function and antibodies, prolactin, glucose tolerance, and pelvic ultrasound. Hysteroscopy or saline infusion sonography identifies septum, polyps, submucosal fibroids, or Asherman syndrome. Three-dimensional ultrasound or magnetic resonance imaging assesses uterine anomalies. Inherited thrombophilia testing is selective. Sperm DNA fragmentation testing in selected men, and karyotype of pregnancy tissue when available, help guide further investigation.

Treatment Options for Recurrent Miscarriage in India

Treatment is directed at identified causes. Antiphospholipid syndrome is treated with low-dose aspirin from before conception and low molecular weight heparin from positive pregnancy test through delivery, giving live birth rates over seventy percent. Uterine septum is corrected hysteroscopically. Submucosal fibroids and polyps are removed hysteroscopically. Asherman syndrome adhesions are released with post-operative oestrogen and an intrauterine device or balloon to prevent reformation. Thyroid disease and diabetes are optimised before conception. For unexplained recurrent miscarriage, supportive care with early scans, progesterone supplementation, and dedicated antenatal follow-up gives live birth rates of around seventy percent. In vitro fertilisation with preimplantation genetic testing for aneuploidy is offered for couples with parental chromosomal translocations or repeated chromosomally abnormal losses. Fortis Memorial Research Institute, Medanta, Apollo, BLK-Max, Manipal, and Jaslok run recurrent pregnancy loss clinics with combined gynaecology, fertility, and immunology input.

Recovery, Success Rates, and Follow-Up

After structured evaluation and targeted treatment, live birth rate in the next pregnancy is sixty to seventy-five percent depending on cause. Antiphospholipid syndrome treatment changes prognosis from twenty percent to over seventy percent live birth rate. Hysteroscopic correction of uterine septum gives live birth rates over seventy percent. Even unexplained recurrent miscarriage has a live birth rate of around seventy percent in the next pregnancy with dedicated care. Early pregnancy support involves scans every two to three weeks until twelve to fourteen weeks, then routine antenatal care.

How to Choose the Right Doctor

Look for a gynaecologist with focused recurrent pregnancy loss practice, ideally working in a dedicated clinic with fertility, immunology, and high-risk obstetric input. Ask whether structured workup follows international guidelines, whether hysteroscopy is part of the evaluation, whether antiphospholipid syndrome and thrombophilia testing are properly interpreted, and whether emotional support and counselling are part of care.

Support for International Patients

Recurrent miscarriage workup and treatment in India, including specialised testing, hysteroscopy, and in vitro fertilisation with preimplantation genetic testing, cost a fraction of equivalent care in the United Kingdom, United States, or Middle East. Cancer Rounds arranges the medical visa invitation letter, airport pickup, accommodation near the treatment hospital, multilingual support in eleven plus languages, and full coordination with the recurrent pregnancy loss clinic. Couples from Nigeria, Bangladesh, Kenya, Ethiopia, Iraq, Oman, the United Arab Emirates, and other countries travel to India for these specialised services.

Frequently Asked Questions

How many miscarriages before testing?

Testing is offered after three consecutive miscarriages. Many centres now offer evaluation after two losses, especially when the woman is older, when losses occurred after fetal heart was seen, or when there are other concerning features.

What is antiphospholipid syndrome?

Antiphospholipid syndrome is an autoimmune clotting disorder that causes recurrent miscarriage, stillbirth, and pregnancy complications. It is diagnosed by repeated positive antiphospholipid antibody testing and treated with low-dose aspirin and low molecular weight heparin, with excellent live birth rates.

Will in vitro fertilisation help?

In vitro fertilisation alone does not improve outcomes in most recurrent miscarriage cases. In vitro fertilisation with preimplantation genetic testing helps couples with parental translocations or repeated chromosomally abnormal losses. For unexplained cases, natural conception with focused early pregnancy support often succeeds.

What is uterine septum?

A uterine septum is a fibrous wall dividing the uterine cavity, a developmental anomaly that increases miscarriage risk. It is corrected hysteroscopically as a day procedure and substantially improves live birth rates.

Can stress cause miscarriage?

Routine daily stress does not cause miscarriage. Most miscarriages are caused by chromosomal abnormalities, antiphospholipid syndrome, structural uterine issues, or medical conditions. Emotional support is still important because the experience of recurrent miscarriage itself is highly distressing.

When can I try again after a miscarriage?

Physically, the body recovers within one to two cycles. Conception in the cycle after miscarriage does not increase further loss risk. Emotional readiness varies. After a workup, treatment can begin before or during the next pregnancy depending on cause.